×

Ovary Tumor Markers and Methods of Use Thereof

  • US 20130004955A1
  • Filed: 10/26/2010
  • Published: 01/03/2013
  • Est. Priority Date: 10/26/2009
  • Status: Active Application
First Claim
Patent Images

1. A tumor marker, for use in the detection of ovary cancer, which is selected from the group consisting of:

  • i) KLRG2, SEQ ID NO;

    85, SEQ ID NO;

    86 or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    85, SEQ ID NO;

    86 or a nucleic acid molecule containing a sequence coding for a KLRG2 protein, said encoding sequence being preferably selected from SEQ ID NO;

    87 and SEQ ID NO;

    88;

    ii) SLC39A10 in one of its variant isoforms SEQ ID NO;

    1, SEQ ID NO;

    2 or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    1 or SEQ ID NO;

    2;

    or a nucleic acid molecule containing a sequence coding for a SLC39A10 protein, said encoding sequence being preferably selected from SEQ ID NO;

    3 and SEQ ID NO;

    4;

    iii) GPR107, in one of its variant isoforms SEQ ID NO;

    5, SEQ ID NO;

    6, SEQ ID NO;

    7, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to any of SEQ ID NO;

    5, SEQ ID NO;

    6, SEQ ID NO;

    7, or a nucleic acid molecule containing a sequence coding for a GPR107 protein, said encoding sequence being preferably selected from SEQ ID NO;

    8, SEQ ID NO;

    9 and SEQ ID NO;

    10;

    iv) DPY19L3, in one of its variant isoforms SEQ ID NO;

    11, SEQ ID NO;

    12, SEQ ID NO;

    13, SEQ ID NO;

    14, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    11, SEQ ID NO;

    12, SEQ ID NO;

    13 or SEQ ID NO;

    14, or a nucleic acid molecule containing a sequence coding for a DPY19L3 protein, said encoding sequence being preferably selected from SEQ ID NO;

    15, SEQ ID NO;

    16, SEQ ID NO;

    17 and SEQ ID NO;

    18;

    v) FLJ42986, SEQ ID NO;

    19 or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    19, or a nucleic acid molecule containing a sequence coding for a FLJ42986 protein, said encoding sequence being preferably SEQ ID NO;

    20;

    vi) COL20A1, in one of its variant isoforms SEQ ID NO;

    21, SEQ ID NO;

    22, SEQ ID NO;

    23, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to any of SEQ ID NO;

    21, SEQ ID NO;

    22, SEQ ID NO;

    23, or a nucleic acid molecule containing a sequence coding for a COL20A1 protein, said encoding sequence being preferably selected from SEQ ID NO;

    24, SEQ ID NO;

    25 and SEQ ID NO;

    26;

    vii) GLT25D2, in one of its variant isoforms SEQ ID NO;

    27, SEQ ID NO;

    28, SEQ ID NO;

    29, SEQ ID NO;

    30, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to any of SEQ ID NO;

    27, SEQ ID NO;

    28, SEQ ID NO;

    29, SEQ ID NO;

    30, or a nucleic acid molecule containing a sequence coding for a GLT25D2 protein, said encoding sequence being preferably selected from SEQ ID NO;

    31, SEQ ID NO;

    32, SEQ ID NO;

    33 and SEQ ID NO;

    34;

    viii) SYTL3, in one of its variant isoforms SEQ ID NO;

    35, SEQ ID NO;

    36, SEQ ID NO;

    37, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to any of SEQ ID NO;

    35, SEQ ID NO;

    36, SEQ ID NO;

    37, or a nucleic acid molecule containing a sequence coding for a SYTL3 protein, said encoding sequence being preferably selected from SEQ ID NO;

    38, SEQ ID NO;

    39 and SEQ ID NO;

    40;

    ix) DENND1B;

    in one of its variant isoforms SEQ ID NO;

    41, SEQ ID NO;

    42, SEQ ID NO;

    43, SEQ ID NO;

    44, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to any of SEQ ID NO;

    41, SEQ ID NO;

    42, SEQ ID NO;

    43, SEQ ID NO;

    44, or a nucleic acid molecule containing a sequence coding for a DENND1B protein, said encoding sequence being preferably selected from SEQ ID NO;

    45, SEQ ID NO;

    46, SEQ ID NO;

    47 and SEQ ID NO;

    48;

    x) FLJ3710, SEQ ID NO;

    49 or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    49, or a nucleic acid molecule containing a sequence coding for a FLJ3710 protein, said encoding sequence being preferably SEQ ID NO;

    50;

    xi) Chromosome 6 orf 98 (C6orf98) SEQ ID NO;

    51 or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    51, or a nucleic acid molecule containing a sequence coding for a C6orf98 protein, said encoding sequence being preferably SEQ ID NO;

    52;

    xii) Family with sequence similarity 69, member B (Fam69B) SEQ ID NO;

    53, SEQ ID NO;

    54 or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    53 or SEQ ID NO;

    54, or a nucleic acid molecule containing a sequence coding for a Fam69B protein, said encoding sequence being preferably selected from SEQ ID NO;

    55 and SEQ ID NO;

    56;

    xiii) EMI domain-containing protein 1 Precursor (EMID1) in one of its variant isoforms SEQ ID NO;

    57, SEQ ID NO;

    58, SEQ ID NO;

    59, SEQ ID NO;

    60, SEQ ID NO;

    61, SEQ ID NO;

    62, SEQ ID NO;

    63, SEQ ID NO;

    64, SEQ ID NO;

    65, SEQ ID NO;

    66, SEQ ID NO;

    67, SEQ ID NO;

    68, SEQ ID NO;

    69, SEQ ID NO;

    70, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    57, SEQ ID NO;

    58, SEQ ID NO;

    59, SEQ ID NO;

    60, SEQ ID NO;

    61, SEQ ID NO;

    62, SEQ ID NO;

    63, SEQ ID NO;

    64, SEQ ID NO;

    65, SEQ ID NO;

    66, SEQ ID NO;

    67, SEQ ID NO;

    68, SEQ ID NO;

    69, SEQ ID NO;

    70, or a nucleic acid molecule containing a sequence coding for a Fam69B protein, said encoding sequence being preferably selected from SEQ ID NO;

    71, SEQ ID NO;

    72, SEQ ID NO;

    73, SEQ ID NO;

    74, SEQ ID NO;

    75, SEQ ID NO;

    76, SEQ ID NO;

    77, SEQ ID NO;

    78, SEQ ID NO;

    79, SEQ ID NO;

    80, SEQ ID NO;

    81, SEQ ID NO;

    82, SEQ ID NO;

    83 and SEQ ID NO;

    84;

    xiv) ERMP1, SEQ ID NO;

    89, SEQ ID NO;

    90 SEQ ID NO;

    91, or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    89, SEQ ID NO;

    90 or SEQ ID NO;

    91, or a nucleic acid molecule containing a sequence coding for a ERMP1 protein, said encoding sequence being preferably selected from SEQ ID NO;

    92, SEQ ID NO;

    93 and SEQ ID NO;

    94;

    xv) VMO1, SEQ ID NO;

    95, SEQ ID NO;

    96, SEQ ID NO;

    97, SEQ ID NO;

    98 or a different isoform having sequence identity of at least 80%, preferably at least 90%, more preferably at least 95% to SEQ ID NO;

    95, SEQ ID NO;

    96, SEQ ID NO;

    97, SEQ ID NO;

    98 or a nucleic acid molecule containing a sequence coding for a VMO1 protein, said encoding sequence being preferably selected from SEQ ID NO;

    99, SEQ ID NO;

    100;

    SEQ ID NO;

    101 and SEQ ID NO;

    102.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×